AMP-Activated Protein Kinase: A Key System Mediating Metabolic Responses to Exercise

Medicine and Science in Sports and Exercise

Volumn 36, Issue 1, 2004, Pages 28-34

  Hardie, D Grahame ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

ATP depletion; Diabetes; Energy sensing; Fatty acid oxidation; Glucose uptake; Metformin

Indexed keywords

ADENOSINE PHOSPHATE; FATTY ACID; GLUCOSE; GLYCOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN KINASE;

AEROBIC METABOLISM; ANAEROBIC METABOLISM; CONFERENCE PAPER; ENZYME ACTIVATION; EUKARYOTE; FATTY ACID METABOLISM; GLUCOSE METABOLISM; GLYCOGEN METABOLISM; MITOCHONDRION; MUSCLE EXERCISE; MUSCLE METABOLISM; NONHUMAN; SACCHAROMYCES CEREVISIAE; SKELETAL MUSCLE;

EID: 0348062846     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.MSS.0000106171.38299.64     Document Type: Conference Paper

References (60)

1. ABU-ELHEIGA, L., W. R. BRINKLEY, L. ZHONG, S. S. CHIRALA, G. WOLDEGIORGIS, and S. J. WAKIL. The subcellular localization of acetyl-CoA carboxylase 2. Proc. Natl. Acad. Sci. USA 97:1444-1449, 2000.
2. ABU-ELHEIGA, L., M. M. MATZUK, K. A. ABO-HASHEMA, and S. J. WAKIL. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613-2616, 2001.
3. AI, H., J. IHLEMANN, Y. HELLSTEN, et al. Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle. Am. J. Physiol. 282:E1291-E1300, 2002.
4. BERGERON, R., S. F. PREVIS, G. W. CLINE, et al. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 50:1076-1082, 2001.
5. BUHL, E. S., N. JESSEN, R. POLD, et al. Long-term A1CAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51:2199-2206, 2002.
6. BUHL, E. S., N. JESSEN, O. SCHMITZ, et al. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 50:12-17, 2001.
7. CARLING, D., K. AGUAN, A. WOODS, et al. Mammalian AMP-activated protein kinase is homologous to yeast and plant protein kinases involved in the regulation of carbon metabolism. J. Biol. Chem. 269:11442-11448, 1994.
8. CARLING, D., and D. G. HARDIE. The substrate and sequence specificity of the AMP-activated protein kinase: phosphorylation of glycogen synthase and phosphorylase kinase. Biochim. Biophys. Acta 1012:81-86, 1989.
9. CARLING, D., V. A. ZAMMIT, and D. G. HARDIE. A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett. 223:217-222, 1987.
10. CARLSON, C. L., and W. W. WINDER. Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise. J. Appl. Physiol. 86:669-674, 1999.
11. CELENZA, J. L., and M. CARLSON. A yeast gene that is essential for release from glucose repression encodes a protein kinase. Science 233:1175-1180, 1986.
12. CHEN, Z. P., G. K. MCCONELL, B. J. MICHELL, R. J. SNOW, B. J. CANNY, and B. E. KEMP. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am. J. Physiol. 279:E1202-E1206, 2000.
13. CHEUNG, P. C. F., I. P. SALT, S. P. DAVIES, D. G. HARDIE, and D. CARLING. Characterization of AMP-activated protein kinase g sub-unit isoforms and their role in AMP binding. Biochem. J. 346: 659-669, 2000.
14. CORTON, J. M., J. G. GILLESPIE, S. A. HAWLEY, and D. G. HARDIE. 5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 229:558-565, 1995.
15. DAVIES, S. P., D. CARLING, and D. G. HARDIE. Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur. J. Biochem. 186:123-128, 1989.
16. DAVIES, S. P., S. A. HAWLEY, A. WOODS, D. CARLING, T. A. J. HAYSTEAD, and D. G. HARDIE. Purification of the AMP-activated protein kinase on ATP-g-Sepharose and analysis of its subunit structure. Eur. J. Biochem. 223:351-357, 1994.
17. DEAN, D., J. R. DAUGAARD, M. E. YOUNG, et al. Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle. Diabetes 49:1295-1300, 2000.
18. DURANTE, P. E., K. J. MUSTARD, S. H. PARK, W. W. WINDER, and D. G. HARDIE. Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. Am. J. Physiol. 283:E178-E186, 2002.
19. FLOTOW, H., and P. J. ROACH. Synergistic phosphorylation of rabbit muscle glycogen synthase by cyclic AMP-dependent protein kinase and casein kinase I. Implications for hormonal regulation of glycogen synthase. J. Biol. Chem. 264:9126-9128, 1989.
20. FUJII, N., T. HAYASHI, M. F. HIRSHMAN, et al. Exercise induces isoform-specific increase in 5′AMP-activated protein kinase activity in human skeletal muscle. Biochem. Biophys. Res. Commun. 273:1150-1155, 2000.
21. HABINOWSKI, S. A., M. HIRSHMAN, K. SAKAMOTO, et al. Malonyl-COA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line. Arch. Biochem. Biophys. 396:71-79, 2001.
22. HARDIE, D. G., and S. A. HAWLEY. AMP-activated protein kinase: the energy charge hypothesis revisited. BioEssays 23:1112-1119, 2001.
23. HARDIE, D. G., I. P. SALT, S. A. HAWLEY, and S. P. DAVIES. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338:717-722, 1999.
24. HAYASHI, T., M. F. HIRSHMAN, E. J. KURTH, W. W. WINDER, and L. J. GOODYEAR. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47:1369-1373, 1998.
25. HENIN, N., M. F. VINCENT, H. E. GRUBER, and G. VAN DEN BERGHE. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J. 9:541-546, 1995.
26. HOLLOSZY, J. O., and E. F. COYLE. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J. Appl. Physiol. 56:831-838, 1984.
27. HOLMES, B. F., E. J. KURTH-KRACZEK, and W. W. WINDER. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J. Appl. Physiol. 87:1990-1995, 1999.
28. HUDSON, E. R., D. A. PAN, J. JAMES, et al. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr. Biol. 13:861-866, 2003.
29. HUTBER, C. A., D. G. HARDIE, and W. W. WINDER. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase activity. Am. J. Physiol. 272:E262-E266, 1997.
30. KISHI, K., T. YUASA, A. MINAMI, et al. AMP-activated protein kinase is activated by the stimulations of G(q)-coupled receptors. Biochem. Biophys. Res. Commun. 276:16-22, 2000.
31. KURTH-KRACZEK, E. J., M. F. HIRSHMAN, L. J. GOODYEAR, and W. W. WINDER. 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48:1667-1671, 1999.
32. LECLERC, I., C. LENZNER, L. GOURDON, S. VAULONT, A. KAHN, and B. VIOLLET. Hepatocyte nuclear factor-4a involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 50:1515-1521, 2001.
33. LONGNUS, S. L., R. B. WAMBOLT, H. L. PARSONS, R. W. BROWNSEY, and M. F. ALLARD. 5-Aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. Am. J. Physiol. 284:R936-R944, 2003.
34. MCGARRY, J. D., and N. F. BROWN. The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. Eur. J. Biochem. 244:1-14, 1997.
35. MCGEE, S. L., K. F. HOWLETT, R. L. STARKIE, D. CAMERON-SMITH, B. E. KEMP, and M. HARGREAVES. Exercise increases nuclear AMPK alpha-2 in human skeletal muscle. Diabetes 52:926-928, 2003.
36. MERRILL, G. M., E. KURTH, D. G. HARDIE, and W. W. WINDER. AICAR decreases malonyl-CoA and increases fatty acid oxidation in skeletal muscle of the rat. Am. J. Physiol. 273:E1107-E1112, 1997.
37. MU, J., J. T. BROZINICK, O. VALLADARES, M. BUCAN, and M. J. BIRNBAUM. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 7:1085-1094, 2001.
38. NIELSEN, J. N., K. J. MUSTARD, D. A. GRAHAM, et al. 5′ -AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J. Appl. Physiol. 94:631-641, 2003.
39. NIELSEN, J. N., J. F. P. WOJTASZEWSKI, R. G. HALLER, et al. Role of 5′-AMP activated protein kinase in exercise regulation of glucose utilization and glycogen synthase activity in skeletal muscle from patients with McArdle's disease. J. Physiol. 541:979-989, 2002.
40. PARK, H., V. K. KAUSHIK, S. CONSTANT, et al. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem. 277:32571-32577, 2002.
41. POLEKHINA, G., A. GUPTA, B. J. MICHELL, et al. AMPK b-subunit targets metabolic stress-sensing to glycogen. Curr. Biol. 13:867-871, 2003.
42. PONTICOS, M., Q. L. LU, J. E. MORGAN, D. G. HARDIE, T. A. PARTRIDGE, and D. CARLING. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J. 17:1688-1699, 1998.
43. RASMUSSEN, B. B., C. R. HANCOCK, and W. W. WINDER. Postexercise recovery of skeletal muscle malonyl-CoA, acetyl-CoA carboxylase, and AMP-activated protein kinase. J. Appl. Physiol. 85:1629-1634, 1998.
44. RASMUSSEN, B. B., and W. W. WINDER. Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase. J. Appl. Physiol. 83:1104-1109, 1997.
45. RICHTER, E. A., W. DERAVE, and J. F. WOJTASZEWSKI. Glucose, exercise and insulin: emerging concepts. J. Physiol. 535:313-322, 2001.
46. SAHA, A. K., A. J. SCHWARSIN, R. RODUIT, et al. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta -D-ribofuranoside [In Process Citation]. J. Biol. Chem. 275:24279-24283, 2000.
47. SIM, A. T. R., and D. G. HARDIE. The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. FEBS Lett. 233:294-298, 1988.
48. STEPHENS, T. J., Z. P. CHEN, B. J. CANNY, B. J. MICHELL, B. E. KEMP, and G. K. MCCONELL. Progressive increase in human skeletal muscle AMPK a2 activity and ACC phosphorylation during exercise. Am. J. Physiol. 282:E688-E694, 2002.
49. VAVVAS, D., A. APAZIDIS, A. K. SAHA, et al. Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J. Biol. Chem. 272:13255-13261, 1997.
50. WINDER, W. W., and D. G. HARDIE. The AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. Am. J. Physiol. 277:E1-E10, 1999.
51. WINDER, W. W., and D. G. HARDIE. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am. J. Physiol. 270:E299-E304, 1996.
52. WINDER, W. W., B. F. HOLMES, D. S. RUBINK, E. B. JENSEN, M. CHEN, and J. O. HOLLOSZY. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol. 88:2219-2226, 2000.
53. WINDER, W. W., H. A. WILSON, D. G. HARDIE, et al. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and cAMP-dependent protein kinase. J. Appl. Physiol. 82:219-225, 1997.
54. WOJTASZEWSKI, J. F., C. MACDONALD, J. N. NIELSEN, et al. Regulation of 5′AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 284:E813-E822, 2003.
55. WOJTASZEWSKI, J. F., P. NIELSEN, B. F. HANSEN, E. A. RICHTER, and B. KIENS. Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J. Physiol. 528:221-226, 2000.
56. WOJTASZEWSKI, J. F. P., S. B. JØRGENSEN, Y. HELLSTEN, D. G. HARDIE, and E. A. RICHTER. Glycogen-dependent effects of AICA riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51:284-292, 2002.
57. YANG, W., Y. H. HONG, X. Q. SHEN, C. FRANKOWSKI, H. S. CAMP, and T. LEFF. Regulation of transcription by AMP-activated Protein Kinase. Phosphorylation of p300 blocks its interaction with nuclear receptors. J. Biol. Chem. 276:38341-38344, 2001.
58. ZHENG, D., P. S. MACLEAN, S. C. POHNERT, et al. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J. Appl. Physiol. 91:1073-1083, 2001.
59. ZHOU, G., R. MYERS, Y. LI, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108: 1167-1174, 2001.
60. ZONG, H., J. M. REN, L. H. YOUNG, et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA 99:15983-15987, 2002.